2015
$75M
from 11 investors over 11 rounds
Arrakis Therapeutics raised $75M on April 18, 2019
Investors: Omega Funds, Nextech Invest, Celgene, WuXi AppTec, GV, venBio Partners and Osage University Partners (OUP)
Arrakis Therapeutics raised $38M on February 27, 2017
Investors: Advent Life Sciences, Celgene, Osage University Partners (OUP) and Canaan